Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **myelin membrane** is a modified, multilamellar extension of the plasma membrane from specialized glial cells (oligodendrocytes in the CNS, Schwann cells in the PNS) that wraps concentrically around axons to form the *myelin sheath*. This membrane is rich in lipids (70–85% of dry mass) and contains specialized proteins such as myelin basic protein (MBP) and proteolipid protein (PLP)[1][4][10]. Its primary function is to electrically insulate axons and enable rapid, saltatory conduction of nerve impulses, crucial for coordinated nervous system activity and metabolic support to neurons[1][3][5][9]. Disruption or loss of myelin membranes underlies many neurological diseases, particularly demyelinating disorders such as multiple sclerosis[2][5]. The "myelin membrane" is not a canonical molecular target for drugs; rather, research and therapies focus on the molecular components of its structure and the cells that produce it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myelin membrane.